These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1123 related items for PubMed ID: 27028170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
    Tramacere F, Arcangeli S, Pignatelli A, Castagna R, Portaluri M.
    Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
    Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA.
    Radiat Oncol; 2014 Feb 04; 9():44. PubMed ID: 24495815
    [Abstract] [Full Text] [Related]

  • 7. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
    Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R.
    Med Oncol; 2018 Nov 27; 36(1):9. PubMed ID: 30483899
    [Abstract] [Full Text] [Related]

  • 8. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
    Hummel S, Simpson EL, Hemingway P, Stevenson MD, Rees A.
    Health Technol Assess; 2010 Oct 27; 14(47):1-108, iii-iv. PubMed ID: 21029717
    [Abstract] [Full Text] [Related]

  • 9. Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: Is there any clinical difference?
    Viani G, Hamamura AC, Faustino AC.
    Int Braz J Urol; 2019 Oct 27; 45(6):1105-1112. PubMed ID: 31808397
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):685-91. PubMed ID: 18718725
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):235-41. PubMed ID: 21163587
    [Abstract] [Full Text] [Related]

  • 16. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D, Sia M, Lockwood G, Moseley D, Rosewall T, Bayley A, Bristow R, Chung P, Ménard C, Milosevic M, Warde P, Catton C.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e415-21. PubMed ID: 21477939
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC, Incrocci L, Pos FJ, van der Heide UA, Lebesque JV, Aluwini S, Witte MG, Heemsbergen WD.
    Int J Radiat Oncol Biol Phys; 2016 Jun 01; 95(2):680-9. PubMed ID: 27055398
    [Abstract] [Full Text] [Related]

  • 19. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C, Vapiwala N, Hwang WT, Lin H, Ad VB, Tochner Z, Both S.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1389-96. PubMed ID: 21664069
    [Abstract] [Full Text] [Related]

  • 20. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):763-72. PubMed ID: 20171807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.